l-carnitine tmao nature medicine 2013 koeth

l-carnitine tmao nature medicine 2013 koeth metaorganismal pathway and chronic inflammatory diseases γ–Butyrobetaine is a pro-atherogenic intermediate

Name: l-carnitine tmao nature medicine 2013 koeth metaorganismal pathway and chronic inflammatory diseases γ–Butyrobetaine is a pro-atherogenic intermediate
Brand: taxivanderwijst.nl
SKU: 76476233979
Price: 28.82 USD
Availability: InStock
Rating: 4.2187 (17 reviews)

Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Gut Microbiome Derived Metabolite Trimethylamine N Oxide Induces Aortic Stiffening and Increases Systolic Blood Pressure With Aging in Mice and Humans Hypertension TMAO (Trimethylamine oxide) biocrates life science Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers Trimethylamine Trimethylamine N Oxide as a Key Between Diet and Cardiovascular Diseases Cardiovascular Toxicology Springer Nature Link

SKU: 76476233979 · From taxivanderwijst.nl

4.2

USD28.82 USD52.82

Pay in 4 interest-free payments of $7.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

CABBI Index, p 881 Stocher T, Plattner G, Tignor M, Allen S, Boschung J, Nauel A, Xia Y, Bex V, Midgley P (2013) Climate change 2013: the physical science basis: Working Group I contribution to the Fifth assessment report of the Intergovernmental Panel on Climate Change